Substituted 5-phenylamino-1,3,4-oxadiazol-2-ylcarb onylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme A diacylglycerol acyltransferase

Details for Australian Patent Application No. 2007266796 (hide)

Owner AstraZeneca AB

Inventors Butlin, Roger John; Plowright, Alleyn

Agent Davies Collison Cave

Pub. Number AU-B-2007266796

PCT Pub. Number WO2007/138311

Priority 60/809,298 30.05.06 US

Filing date 29 May 2007

Wipo publication date 6 December 2007

Acceptance publication date 10 February 2011

International Classifications

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/138311 Priority application(s): WO2007/138311

10 February 2011 Application Accepted

  Published as AU-B-2007266796

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007266797-Liquid dispenser that uses two pressure levels

2007266791-Hydrophilized anode for a direct liquid fuel cell